Home › Lupus Nephritis › New Jersey
Lupus Nephritis clinical trials in New Jersey
5 studies for Lupus Nephritis are looking for participants at sites in New Jersey.
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Hackensack University Medical Center, Hackensack
RecruitingPhase 2
Ages 8 to 20 · All sexes · Updated Sep 14, 2026 · NCT05538208A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Astera Cancer Care, East Brunswick
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Hackensack University Medical Center, Hackensack
RecruitingPhase 2
Ages 5 to 17 · All sexes · Updated Sep 3, 2026 · NCT05039619PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Sahni Rheumatology & Therapy, West Long Branch
RecruitingPhase 4
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT07611214A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Nkarta Investigational Site, Summit
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Jun 4, 2026 · NCT06557265From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.